Medullary sponge kidney

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1309Q61.5
Who is this for?
Show terms as
5Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Medullary sponge kidney (MSK), also known as Cacchi-Ricci disease or precalyceal canalicular ectasia, is a congenital malformation of the kidneys characterized by dilation (ectasia) of the collecting tubules in the renal medulla, giving the kidney a sponge-like appearance on imaging. The dilated tubules can be found in one or both kidneys and may affect one or several renal papillae. The condition primarily affects the urinary system and is often discovered incidentally during imaging studies performed for other reasons. Many individuals with medullary sponge kidney remain asymptomatic throughout their lives. However, the dilated collecting ducts predispose to urinary stasis, which can lead to recurrent kidney stones (nephrolithiasis), recurrent urinary tract infections, and hematuria (blood in the urine). Kidney stones, typically composed of calcium oxalate or calcium phosphate, are the most common clinical manifestation and may cause renal colic (flank pain). Some patients also develop nephrocalcinosis (calcium deposits within the kidney tissue). A defect in urinary acidification and hypercalciuria (excess calcium in the urine) are frequently observed metabolic abnormalities. Renal function is generally preserved, though complications from recurrent stones or infections can occasionally lead to impaired kidney function over time. There is no cure for medullary sponge kidney, and treatment is directed at managing symptoms and preventing complications. Management strategies include adequate hydration to reduce stone formation, dietary modifications, and thiazide diuretics or potassium citrate to address hypercalciuria and urinary acidification defects. Urinary tract infections are treated with appropriate antibiotics. Kidney stones may require intervention such as extracorporeal shock wave lithotripsy or ureteroscopy if they cause obstruction or significant symptoms. Regular follow-up with a nephrologist or urologist is recommended to monitor kidney function and manage recurrent stone disease.

Also known as:

Clinical phenotype terms— hover any for plain English:

HemihypertrophyHP:0001528Distal renal tubular acidosisHP:0008341
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Apr 2026A Clinical Study Comparing the Bioequivalence of IBI3027 and DUPIXENT®(Dupilumab) in Healthy Chinese Volunteers

Innovent Biologics (Suzhou) Co. Ltd. — PHASE1

TrialNOT YET RECRUITING
Apr 2026A Comparison of Clinical Efficacy of Mytocel MSK With AMT and PRP Injections in Patients With Knee Osteoarthritis

Taichung Veterans General Hospital — EARLY_PHASE1

TrialNOT YET RECRUITING
Mar 2026Upneeq vs. Lumify Ptosis

Duke University — PHASE4

TrialNOT YET RECRUITING
Mar 2026A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular Degeneration

Qilu Pharmaceutical Co., Ltd. — PHASE3

TrialNOT YET RECRUITING
Feb 2026Percutaneous Transcatheter Genicular Embolization in Osteoarthritis

Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. — NA

TrialRECRUITING
Jan 2026PRISM: The PRimary Care Individual Social Norms MSK Data Dashboard: a Feasibility Trial

University College, London — NA

TrialNOT YET RECRUITING
Nov 2025Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

ADARx Pharmaceuticals, Inc. — PHASE2

TrialRECRUITING
Nov 2025Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

AbbVie — PHASE3

TrialRECRUITING
Nov 2025Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).

Instituto Grifols, S.A. — PHASE2

TrialRECRUITING
Oct 2025Walking Football for Axial Spondyloarthritis

Portsmouth Hospitals NHS Trust — NA

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Medullary sponge kidney.

View clinical trials →

No actively recruiting trials found for Medullary sponge kidney at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Medullary sponge kidney community →

Specialists

5 foundView all specialists →
FM
Francis W Price, MD
Specialist
PI on 2 active trials
DM
Daniel Magilavy, MD
Specialist
PI on 2 active trials
TM
Theresa Heah, MD
Specialist
PI on 4 active trials
GM
Gail Torkildsen, MD
ANDOVER, MA
Specialist
PI on 6 active trials1 Medullary sponge kidney publication
FM
Flavio Mantelli, MD
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Medullary sponge kidney.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Medullary sponge kidneyForum →

No community posts yet. Be the first to share your experience with Medullary sponge kidney.

Start the conversation →

Latest news about Medullary sponge kidney

Disease timeline:

New recruiting trial: TArgeting Type 1 Diabetes Using POLyamines (TADPOL)

A new clinical trial is recruiting patients for Medullary sponge kidney

New recruiting trial: Gentamicin Open Tibia Study

A new clinical trial is recruiting patients for Medullary sponge kidney

New recruiting trial: Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol

A new clinical trial is recruiting patients for Medullary sponge kidney

New recruiting trial: Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

A new clinical trial is recruiting patients for Medullary sponge kidney

New recruiting trial: Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone

A new clinical trial is recruiting patients for Medullary sponge kidney

New recruiting trial: A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME

A new clinical trial is recruiting patients for Medullary sponge kidney

New recruiting trial: Percutaneous Transcatheter Genicular Embolization in Osteoarthritis

A new clinical trial is recruiting patients for Medullary sponge kidney

New recruiting trial: Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis

A new clinical trial is recruiting patients for Medullary sponge kidney

New recruiting trial: A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

A new clinical trial is recruiting patients for Medullary sponge kidney

New recruiting trial: Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension

A new clinical trial is recruiting patients for Medullary sponge kidney

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Medullary sponge kidney

What is Medullary sponge kidney?

Medullary sponge kidney (MSK), also known as Cacchi-Ricci disease or precalyceal canalicular ectasia, is a congenital malformation of the kidneys characterized by dilation (ectasia) of the collecting tubules in the renal medulla, giving the kidney a sponge-like appearance on imaging. The dilated tubules can be found in one or both kidneys and may affect one or several renal papillae. The condition primarily affects the urinary system and is often discovered incidentally during imaging studies performed for other reasons. Many individuals with medullary sponge kidney remain asymptomatic throug

At what age does Medullary sponge kidney typically begin?

Typical onset of Medullary sponge kidney is adult. Age of onset can vary across affected individuals.

Which specialists treat Medullary sponge kidney?

5 specialists and care centers treating Medullary sponge kidney are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.